$BRZH
Breeze Holdings Acquisition Corp. Stock $brzh

$brzh Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000156459023007275 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$300.0K	$890.1K	$985.1K
YoY Change	200.0%	-9.64%	347.06%
Operating Profit	-$303.3K	-$890.1K	-$985.1K
YoY Change	197.69%	-9.64%	347.06%
Interest Expense	$152.2K	$68.33K	$52.88K
YoY Change		29.21%	10962.76%
% of Operating Profit
Other Income/Expense, Net	-$1.202M	$237.6K	$3.553M
YoY Change	-231.7%	-93.31%	-40.75%
Pretax Income	-$1.505M	-$652.6K	$2.568M
YoY Change	-285.68%	-125.41%	-55.55%
Income Tax	$5.149K	$1.709K
% Of Pretax Income
Net Earnings	-$1.510M	-$654.3K	$2.568M
YoY Change	-286.32%	-125.48%	-55.55%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.35	-$0.14	$0.18
Diluted Earnings Per Share	-$0.35	-$0.14	$175.4K
COMMON SHARES
Basic Shares Outstanding	4.320M	4.320M	14.64M
Diluted Shares Outstanding	4.320M shares	4.779M	14.64M

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$0.00	$37.57K	$9.640K
YoY Change		289.73%	-97.21%
Cash & Equivalents	$3.184K	$37.57K	$9.642K
Short-Term Investments
Other Short-Term Assets	$100.0K	$169.5K	$101.6K
YoY Change	-50.0%	66.78%	-59.59%
Inventory
Prepaid Expenses	$149.0K	$149.6K
Receivables
Other Receivables
Total Short-Term Assets	$170.8K	$207.0K	$111.3K
YoY Change	0.73%	86.08%	-81.37%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$12.80M	$12.56M	$119.1M
YoY Change	-74.09%	-89.45%	2.04%
Other Assets
YoY Change
Total Long-Term Assets	$12.84M	$12.56M	$119.1M
YoY Change	-74.01%	-89.45%	2.04%
TOTAL ASSETS
Total Short-Term Assets	$170.8K	$207.0K	$111.3K
Total Long-Term Assets	$12.84M	$12.56M	$119.1M
Total Assets	$13.01M	$12.77M	$119.2M
YoY Change	-73.75%	-89.29%	1.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$100.0K	$338.2K	$1.258M
YoY Change	-88.89%	-73.12%	3210.21%
Accrued Expenses	$100.0K	$71.55K	$249.3K
YoY Change	0.0%	-71.3%	405.52%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$281.0K
YoY Change	-100.0%	-100.0%
Long-Term Debt Due	$6.807M	$6.251M
YoY Change	193.25%
Total Short-Term Liabilities	$7.057M	$6.660M	$4.114M
YoY Change	69.43%	61.91%	1824.29%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.400M	$1.016M	$3.609M
YoY Change	-14.29%	-71.86%	-68.65%
Total Long-Term Liabilities	$2.400M	$1.016M	$3.609M
YoY Change	-14.29%	-71.86%	-68.65%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.057M	$6.660M	$4.114M
Total Long-Term Liabilities	$2.400M	$1.016M	$3.609M
Total Liabilities	$9.426M	$7.676M	$7.722M
YoY Change	36.08%	-0.6%	-34.13%
SHAREHOLDERS EQUITY
Retained Earnings	-$9.048M	-$7.413M
YoY Change	34.93%
Common Stock	$315.00	$315.00
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$9.047M	-$7.413M	-$7.501M
YoY Change
Total Liabilities & Shareholders Equity	$13.01M	$12.77M	$119.2M
YoY Change	-73.75%	-89.29%	1.62%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$1.510M	-$654.3K	$2.568M
YoY Change	-286.32%	-125.48%	-55.55%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$460.0K	-$586.6K	-$276.8K
YoY Change	-36.11%	111.94%	-20.46%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$110.0K	$5.223M	-$1.150M
YoY Change	-100.16%	-554.17%
Cash From Investing Activities	-$110.0K	$5.223M	-$1.150M
YoY Change	-100.16%	-554.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	540.0K	-4.613M	1.431M
YoY Change	-100.78%	-422.36%
NET CHANGE
Cash From Operating Activities	-460.0K	-586.6K	-276.8K
Cash From Investing Activities	-110.0K	5.223M	-1.150M
Cash From Financing Activities	540.0K	-4.613M	1.431M
Net Change In Cash	-30.00K	23.44K	4.239K
YoY Change		452.96%	-101.22%
FREE CASH FLOW
Cash From Operating Activities	-$460.0K	-$586.6K	-$276.8K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Entity File Number EntityFileNumber	001-39718
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	500-7747
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4320484
CY2023Q1	us-gaap	Cash Cash	37569
CY2022Q4	us-gaap	Cash Cash	14129
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3140000
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3140000
CY2023Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1180484
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-7413298
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-7412983
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12770034
CY2023Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	890129
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-3500000
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3552883
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-7412983
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	237577
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Shell Company EntityShellCompany	true
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-985093
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	169250
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1015500
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001817640
CY2023Q1	brez	Minimum Number Of Business Days To Redeem Public Shares MinimumNumberOfBusinessDaysToRedeemPublicShares	P10D
CY2023Q1	brez	Warrants Redemption Covenant Threshold Trading Days WarrantsRedemptionCovenantThresholdTradingDays	P20D
CY2023Q1	brez	Warrants Redemption Covenant Threshold Consecutive Trading Days WarrantsRedemptionCovenantThresholdConsecutiveTradingDays	P30D
CY2023Q1	brez	Number Of Business Days Before Sending Notice Of Redemption Period NumberOfBusinessDaysBeforeSendingNoticeOfRedemptionPeriod	P3D
CY2023Q1	brez	Number Of Trading Days Prior On Consummates Business Combination NumberOfTradingDaysPriorOnConsummatesBusinessCombination	P20D
CY2023Q1	brez	Warrants Will Not Be Transferable Assignable Or Saleable Number Of Period After Completion Of Business Combination WarrantsWillNotBeTransferableAssignableOrSaleableNumberOfPeriodAfterCompletionOfBusinessCombination	P30D
CY2023Q1	brez	Business Combination Right Convertible Share Of Common Stock Conversion Ratio BusinessCombinationRightConvertibleShareOfCommonStockConversionRatio	0.05
CY2023Q1	brez	Business Combination Right Convertible Share Of Common Stock Conversion Ratio BusinessCombinationRightConvertibleShareOfCommonStockConversionRatio	0.05
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	BREEZE HOLDINGS ACQUISITION CORP.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-1849315
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	955 W. John Carpenter Freeway
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 100-929
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Irving
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75039
CY2023Q1	dei	City Area Code CityAreaCode	619
CY2023Q1	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	18672
CY2022Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	18073
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	149647
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	160503
CY2022Q4	brez	Prepayment Franchise Taxes Current PrepaymentFranchiseTaxesCurrent	10000
CY2023Q1	brez	Prepaid Income Taxes Current PrepaidIncomeTaxesCurrent	1149
CY2023Q1	us-gaap	Assets Current AssetsCurrent	207037
CY2022Q4	us-gaap	Assets Current AssetsCurrent	202705
CY2023Q1	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	12562997
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	17730969
CY2023Q1	us-gaap	Assets Assets	12770034
CY2022Q4	us-gaap	Assets Assets	17933674
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	338168
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	67500
CY2023Q1	brez	Franchise Tax Payable FranchiseTaxPayable	17590
CY2023Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	53959
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2089
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	6250572
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	5480941
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	6660289
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5550530
CY2023Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1015500
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1184750
CY2023Q1	us-gaap	Liabilities Liabilities	7675789
CY2022Q4	us-gaap	Liabilities Liabilities	6735280
CY2023Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1180484
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1690196
CY2023Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	12507228
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	17730156
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3140000
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3140000
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1690196
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	315
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	315
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6532077
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-6531762
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17933674
CY2022Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	985093
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-890129
CY2023Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	68327
CY2022Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	52883
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-169250
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-652552
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2567790
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1709
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-654261
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	2567790
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4779225
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4779225
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14640000
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14640000
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.18
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.18
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-6531762
CY2023Q1	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	173001
CY2023Q1	brez	Equity Adjustment Related To Excise Taxes Payable EquityAdjustmentRelatedToExciseTaxesPayable	53959
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-654261
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-8919146
CY2022Q1	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	1150000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	2567790
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-7501356
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-654261
CY2022Q1	us-gaap	Profit Loss ProfitLoss	2567790
CY2023Q1	brez	Interest And Unrealized Gain Loss On Investments InterestAndUnrealizedGainLossOnInvestments	68327
CY2022Q1	brez	Interest And Unrealized Gain Loss On Investments InterestAndUnrealizedGainLossOnInvestments	52883
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-169250
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-3500000
CY2023Q1	brez	Increase Decrease In Prepaid Expenses And Other Liabilities IncreaseDecreaseInPrepaidExpensesAndOtherLiabilities	-19109
CY2022Q1	brez	Increase Decrease In Prepaid Expenses And Other Liabilities IncreaseDecreaseInPrepaidExpensesAndOtherLiabilities	-22542
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	270668
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	659767
CY2023Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-2089
CY2023Q1	brez	Increase Decrease In Franchise Taxes Payable IncreaseDecreaseInFranchiseTaxesPayable	17590
CY2022Q1	brez	Increase Decrease In Franchise Taxes Payable IncreaseDecreaseInFranchiseTaxesPayable	49315
CY2022Q1	brez	Increase Decrease In Current Portion Of Long Term Liabilities IncreaseDecreaseInCurrentPortionOfLongTermLiabilities	-23292
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-586560
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-276761
CY2023Q1	us-gaap	Payments To Acquire Trust Preferred Investments PaymentsToAcquireTrustPreferredInvestments	173001
CY2022Q1	us-gaap	Payments To Acquire Trust Preferred Investments PaymentsToAcquireTrustPreferredInvestments	1150000
CY2023Q1	brez	Cash Withdrawn From Trust Account To Redeeming Shareholders CashWithdrawnFromTrustAccountToRedeemingShareholders	5395929
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	5222928
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1150000
CY2023Q1	brez	Proceeds From Short Term Working Capital Loan Related Party ProceedsFromShortTermWorkingCapitalLoanRelatedParty	610000
CY2022Q1	brez	Proceeds From Short Term Working Capital Loan Related Party ProceedsFromShortTermWorkingCapitalLoanRelatedParty	281000
CY2023Q1	brez	Proceeds From Promissory Note Related Party ProceedsFromPromissoryNoteRelatedParty	173001
CY2022Q1	brez	Proceeds From Promissory Note Related Party ProceedsFromPromissoryNoteRelatedParty	1150000
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	5395929
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4612928
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1431000
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	23440
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4239
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14129
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5403
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	37569
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	9642
CY2023Q1	brez	Non Cash Excise Taxes Payable NonCashExciseTaxesPayable	53959
CY2023Q1	brez	Accretion Of Common Stocks Subject To Redemption Value AccretionOfCommonStocksSubjectToRedemptionValue	173001
CY2022Q1	brez	Accretion Of Common Stocks Subject To Redemption Value AccretionOfCommonStocksSubjectToRedemptionValue	1150000
CY2020Q4	brez	Sale Of Private Placement Warrants SaleOfPrivatePlacementWarrants	5425000
CY2020Q4	brez	Cost Of Per Private Placement Warrant CostOfPerPrivatePlacementWarrant	1.00
CY2020Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	4099907
CY2020Q4	brez	Underwriting Fees UnderwritingFees	2300000
CY2020Q4	brez	Other Offering Costs OtherOfferingCosts	477557
CY2023Q1	us-gaap	Cash Cash	37569
CY2023Q1	brez	Aggregate Fair Market Value Of Acquisition Threshold As Percentage Of Assets Held In Trust Account AggregateFairMarketValueOfAcquisitionThresholdAsPercentageOfAssetsHeldInTrustAccount	0.80
CY2023Q1	brez	Minimum Voting Interest To Be Owned Or Acquired To Complete Business Combination MinimumVotingInterestToBeOwnedOrAcquiredToCompleteBusinessCombination	0.50
CY2023Q1	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.15
CY2023Q1	brez	Business Combination Minimum Threshold Limit Of Net Intangible Assets Required BusinessCombinationMinimumThresholdLimitOfNetIntangibleAssetsRequired	5000001
CY2023Q1	brez	Restriction On Public Share Redemption In Case Of Stockholder Approval Of Business Combination RestrictionOnPublicShareRedemptionInCaseOfStockholderApprovalOfBusinessCombination	0.10
CY2023Q1	brez	Business Combination Incomplete Percentage Of Stock Redemption BusinessCombinationIncompletePercentageOfStockRedemption	1
CY2022Q2	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.35
CY2022Q2	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	6732987
CY2022Q2	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	69700628
CY2022Q2	brez	Cash Withdrawn From Trust Account CashWithdrawnFromTrustAccount	109000
CY2022Q3	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.35
CY2022Q3	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	3076817
CY2022Q3	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	31845056
CY2022Q3	brez	Cash Withdrawn From Trust Account CashWithdrawnFromTrustAccount	122247
CY2022Q3	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.035
CY2022Q3	us-gaap	Temporary Equity Value Excluding Additional Paid In Capital TemporaryEquityValueExcludingAdditionalPaidInCapital	59157
CY2022Q3	us-gaap	Temporary Equity Value Excluding Additional Paid In Capital TemporaryEquityValueExcludingAdditionalPaidInCapital	59157
CY2023Q1	brez	Business Combination Completion Date Of Acquisition BusinessCombinationCompletionDateOfAcquisition	2023-09-26
CY2023Q1	brez	Business Combination Incomplete Maximum Dissolution Expenses To Be Paid BusinessCombinationIncompleteMaximumDissolutionExpensesToBePaid	100000
CY2023Q1	brez	Assets Remaining Available For Distribution Per Share Maximum AssetsRemainingAvailableForDistributionPerShareMaximum	10.595
CY2022Q4	brez	Business Combination Expected To Close BusinessCombinationExpectedToClose	third quarter of 2023
CY2023Q1	us-gaap	Cash Cash	37569
CY2023Q1	brez	Working Capital WorkingCapital	6381703
CY2020Q4	brez	Proceeds From Sale Of Founder Shares ProceedsFromSaleOfFounderShares	25000
CY2020Q4	brez	Proceeds From Unsecured And Non Interest Bearing Promissory Notes ProceedsFromUnsecuredAndNonInterestBearingPromissoryNotes	300000
CY2023Q1	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	509712
CY2023Q1	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	5400000
CY2023Q1	brez	Percentage Of Excise Tax On Redemption Amount Paid PercentageOfExciseTaxOnRedemptionAmountPaid	0.01
CY2023Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	53959
CY2023Q1	brez	Percentage Of Excise Tax Liability Shares Redeemed PercentageOfExciseTaxLiabilitySharesRedeemed	0.01
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of estimates</p> <p style="margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</p> <p style="margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p>
CY2023Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0
CY2022Q2	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	6732987
CY2022Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	4767013
CY2022Q3	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.35
CY2022Q3	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	3076817
CY2022Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1690196
CY2023Q1	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.56
CY2023Q1	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	509712
CY2023Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1180484
CY2023Q1	brez	Offering Costs Incurred In Connection With Issuance Of Common Stock OfferingCostsIncurredInConnectionWithIssuanceOfCommonStock	3704282
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2023Q1	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0
CY2022Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-654261
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	2567790
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4779225
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4779225
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14640000
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14640000
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.18
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.18
CY2023Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Concentration of credit risk</p> <p style="margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the FDIC coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</p>
CY2023Q1	us-gaap	Concentration Risk Credit Risk Financial Instrument Maximum Exposure ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure	250000
CY2023Q1	brez	Percentage Of Advisor Cash Fee On Gross Proceeds Of Initial Public Offering PercentageOfAdvisorCashFeeOnGrossProceedsOfInitialPublicOffering	0.0275
CY2023Q1	brez	Cash Fee For Advisory Services Upon Consummation Of Business Combination CashFeeForAdvisoryServicesUponConsummationOfBusinessCombination	3162500
CY2023Q1	brez	Number Of Fractional Shares Issued Upon Exercise Of Public Warrant NumberOfFractionalSharesIssuedUponExerciseOfPublicWarrant	0
CY2023Q1	brez	Warrants Exercisable Period After Completion Of Business Combination WarrantsExercisablePeriodAfterCompletionOfBusinessCombination	P30D
CY2023Q1	brez	Warrants Exercisable Period From Closing Of Initial Public Offering WarrantsExercisablePeriodFromClosingOfInitialPublicOffering	P12M
CY2023Q1	brez	Warrant Expiration Period After Completion Of Business Combination Or Earlier Upon Redemption Or Liquidation WarrantExpirationPeriodAfterCompletionOfBusinessCombinationOrEarlierUponRedemptionOrLiquidation	P5Y
CY2023Q1	brez	Class Of Warrant Or Right Exercisable ClassOfWarrantOrRightExercisable	0
CY2023Q1	brez	Class Of Warrant Or Right Redemption Price ClassOfWarrantOrRightRedemptionPrice	0.01
CY2023Q1	brez	Minimum Period Of Prior Written Notice Of Redemption Of Warrants MinimumPeriodOfPriorWrittenNoticeOfRedemptionOfWarrants	P30D
CY2023Q1	brez	Minimum Price Per Share Required For Redemption Of Warrants MinimumPricePerShareRequiredForRedemptionOfWarrants	18.00
CY2023Q1	brez	Maximum Effective Issue Price To Closing Of Business Combination MaximumEffectiveIssuePriceToClosingOfBusinessCombination	9.20
CY2023Q1	brez	Minimum Percentage Of Equity Proceeds From Issuances MinimumPercentageOfEquityProceedsFromIssuances	0.60
CY2023Q1	brez	Percentage Of Exercise Price Of Warrants Adjusted Equal To Higher Of Market Value And Issued Price PercentageOfExercisePriceOfWarrantsAdjustedEqualToHigherOfMarketValueAndIssuedPrice	1.15
CY2023Q1	brez	Minimum Price Per Share Required For Redemption Of Warrants MinimumPricePerShareRequiredForRedemptionOfWarrants	18.00
CY2023Q1	brez	Percentage Of Redemption Triggered Price Of Warrants Adjusted Equal To Higher Of Market Value And Issued Price PercentageOfRedemptionTriggeredPriceOfWarrantsAdjustedEqualToHigherOfMarketValueAndIssuedPrice	1.80
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	5425000
CY2023Q1	brez	Warrant Price Per Share WarrantPricePerShare	1.00
CY2023Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	5425000
CY2023Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-169250
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-3500000
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Voting Rights CommonStockVotingRights	Holders of common stock are entitled to one vote for each share.
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3140000
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3140000
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3140000
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3140000
CY2023Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1180484
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1690196
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	0
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	0
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	0
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	0
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3	0
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3	0
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3	0
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3	0
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	7108500
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	3500000
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	3608500
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1184750
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0026
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21

Files In Submission

Name	View Source	Status
0001564590-23-007275-index-headers.html	Edgar Link	pending
0001564590-23-007275-index.html	Edgar Link	pending
0001564590-23-007275.txt	Edgar Link	pending
0001564590-23-007275-xbrl.zip	Edgar Link	pending
brez-10q_20230331.htm	Edgar Link	pending
brez-20230331.xsd	Edgar Link	pending
brez-ex311_9.htm	Edgar Link	pending
brez-ex321_7.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
brez-20230331_def.xml	Edgar Link	unprocessable
brez-20230331_lab.xml	Edgar Link	unprocessable
brez-20230331_pre.xml	Edgar Link	unprocessable
brez-10q_20230331_htm.xml	Edgar Link	completed
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
brez-20230331_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BRZH
Breeze Holdings Acquisition Corp. Stock $brzh

2023 Q2 Form 10-Q Financial Statement

#000156459023007275 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BRZH Breeze Holdings Acquisition Corp. Stock $brzh

2023 Q2 Form 10-Q Financial Statement

#000156459023007275 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BRZH
Breeze Holdings Acquisition Corp. Stock $brzh